Healthline Daily

 The Global Inferior Vena Cava (IVC) Filter Market is expected to rise from US$ 0.8 billion in 2024 to nearly US$ 1.9 billion by 2034, registering a CAGR of 8.8% from 2025 to 2034. In 2024, North America dominated the market, accounting for over 40.6% share, with revenues reaching US$ 0.3 billion . A key factor driving this growth is the increasing number of patients diagnosed with deep vein thrombosis (DVT) and pulmonary embolism (PE). When blood thinners are not safe or do not work effectively, doctors often use IVC filters, increasing demand for these devices. The aging global population is another major growth driver. Older individuals, especially those suffering from heart disease or cancer, are more likely to develop blood clots. As global life expectancy increases, so does the need for preventive treatments. In surgical recovery and trauma care where blood thinners are not recommended IVC filters provide a safe alternative. These clinical needs are steadily expanding the...

 The Root Canal Irrigators Market is projected to grow from USD 182.1 million in 2024 to USD 311.1 million by 2034, at a CAGR of 5.5% . One major growth driver is the rising number of people with oral health problems. According to the World Health Organization, dental issues like tooth decay and gum disease are common across all age groups. These conditions often lead to serious tooth infections that require root canal treatment. As a result, the demand for efficient cleaning tools such as irrigators is increasing. The growing preference for saving natural teeth has made root canal treatment more common. Dentists now focus on cleaning infected tooth roots instead of extracting them. Root canal irrigators are essential in this process. They help remove bacteria and debris from deep within the canals. At the same time, there is a stronger push toward infection control in dental care. Advanced irrigators play a key role in improving hygiene and treatment success rates, making the...

 The Portable Medical Electronic Products market is projected to grow from USD 83.2 billion in 2024 to around USD 204.3 billion by 2034, with a strong CAGR of 9.4% . A major growth factor is the rising number of people with long-term health conditions. According to the World Health Organization (WHO), illnesses like diabetes, heart disease, and respiratory disorders are becoming more common. Portable devices such as glucose monitors, blood pressure meters, and heart rate trackers help patients manage their conditions from home and reduce hospital visits. Another key driver is the growing elderly population. As people live longer, they often need regular health monitoring. Portable medical devices offer a simple and non-invasive way to do this. Seniors can track their health daily without leaving home. These devices help older adults maintain independence while sharing vital data with doctors and caregivers. Their user-friendly design makes them ideal for home use in both develop...

 The Global Cryo-Electron Microscopy (Cryo-EM) market is expected to grow significantly, reaching approximately USD 4.2 billion by 2034, up from USD 1.4 billion in 2024. This growth represents a strong CAGR of 11.5% over the forecast period. In 2024, North America dominated the market with a 39.6% share, generating nearly USD 0.6 billion in revenue. Cryo-EM is gaining importance in health research for its ability to capture high-resolution images of cells, proteins, and viruses. These insights are vital for advancing disease research, drug discovery, and vaccine development. A key driver of this market is the strong backing from national and global health organizations. In the United States, the National Institutes of Health (NIH) supports Cryo-EM centers that provide affordable or free access to researchers. This support is expanding the use of Cryo-EM beyond elite institutions to include smaller labs and public health facilities. Several countries are also investing in sha...

 The Global Veterinary Microchips Market is projected to grow from USD 730.2 million in 2024 to USD 1946.2 million by 2034, at a CAGR of 10.3% during the forecast period. One of the main factors driving this growth is the increasing adoption of pets. As more people treat pets like family, demand for safe and permanent identification methods is rising. Microchips provide a reliable way to track and identify animals, giving pet owners peace of mind. This trend is especially strong in urban areas. Government regulations are another major factor supporting market expansion. Many countries have made pet microchipping mandatory, especially for dogs and cats. These laws aim to reduce the number of stray and abandoned animals. They also help promote responsible pet ownership. As more regions implement such laws, demand for veterinary microchips is expected to rise. The push for animal identification is often linked to broader efforts in animal control and welfare management. Technologi...

 The Global Image-Guided and Robot-Assisted Surgical Procedures Market is expected to grow from USD 3.6 billion in 2024 to USD 13.9 billion by 2034, at a CAGR of 14.3% . In 2023, North America dominated the market with a 46.4% share, generating USD 1.67 billion in revenue. This growth is largely driven by the rising number of chronic diseases, including cancer, heart conditions, and neurological disorders. These health issues often require complex surgeries, where precision and safety are critical. Advanced surgical systems are helping meet this demand. Rapid advancements in medical technology are also playing a major role. Modern systems now combine 3D imaging, artificial intelligence, and real-time navigation to guide surgical tools with greater accuracy. These innovations enable minimally invasive procedures, which lead to faster recovery, less pain, and fewer complications. Backed by global health organizations, these tools are being widely adopted to improve surgical qual...

 The Global Medical Telepresence Robots Market is projected to grow from USD 80.6 billion in 2024 to USD 439.3 billion by 2034. This represents a strong CAGR of 18.3% . A key factor behind this growth is the rising use of telemedicine. Supported by the World Health Organization and various national health agencies, telemedicine helps extend care to more people. Telepresence robots make this possible by allowing real-time doctor-patient interaction without physical presence. This trend gained momentum during health crises and continues post-pandemic. A major driver is the global shortage of healthcare professionals, especially in rural and underserved regions. Many hospitals lack access to enough trained doctors and nurses. Telepresence robots allow specialists to assist remotely. This supports local teams by offering expert input without delay. As a result, these robots improve access and reduce health disparities. They also make advanced care available in smaller clinics and fa...

 The Global Metabolic Testing Market is expected to grow from USD 0.8 billion in 2024 to USD 1.6 billion by 2034, registering a CAGR of 7.2% . In 2024, North America led the market with a 39.6% share and revenue of approximately USD 0.3 billion . The growing burden of metabolic disorders like diabetes, obesity, and high cholesterol is a major growth driver. These conditions often go unnoticed until they become severe, which highlights the importance of early and regular metabolic testing. Advances in technology are making metabolic testing quicker, easier, and more accurate. Many new devices are non-invasive and can track metabolic activity continuously without the need for blood samples. These innovations support a wider shift towards preventive and personalized healthcare. Individuals are increasingly interested in understanding their body’s metabolism to make informed lifestyle choices. As a result, fitness centers, wellness clinics, and nutrition experts are adopting these...

 The Global Tonometers Market is expected to grow from US$ 0.4 billion in 2024 to US$ 0.8 billion by 2034, at a steady CAGR of 6.3% . This growth is mainly driven by increased awareness of eye health and the need for early detection of conditions like glaucoma and ocular hypertension. These issues are rising, especially among the elderly and people with chronic illnesses. As a result, health authorities now recommend regular eye pressure checks, increasing demand for tonometers across healthcare settings. An aging population is one of the key factors fueling this market. Older adults are more likely to suffer from vision-related problems and require regular monitoring. In parallel, chronic illnesses such as diabetes are contributing to the rise in eye disorders, including diabetic retinopathy. Many diabetic care programs, especially those supported by governments, include routine tonometry. This trend is pushing the adoption of tonometers in clinics, hospitals, and even home bas...

 The Global Hospital Gowns Market is expected to grow from US$ 2.6 billion in 2024 to US$ 5.7 billion by 2034, at a CAGR of 8.2% during 2025–2034. In 2024, North America led the market with over 39.5% share, generating around US$ 1.0 billion in revenue. Growth is being driven by rising infection control efforts, improved healthcare systems, and technological innovation in gown design and materials. A key growth driver is the increased focus on infection prevention. Global health agencies like the WHO and CDC recommend using hospital gowns to prevent the spread of infections in clinical settings. Gowns provide protection for both healthcare workers and patients. With hygiene becoming a top priority, demand for certified, high-quality gowns continues to rise. Another major factor is the rise in surgeries and complex treatments. As more patients undergo cancer care, organ transplants, and other advanced procedures, hospitals need reliable protective clothing. Gowns are used acro...

 The Global Advanced Drug Delivery Systems Market is projected to reach approximately US$ 439.7 billion by 2034, up from US$ 255 billion in 2024, growing at a CAGR of 5.6% from 2025 to 2034. This growth is driven by the rising burden of chronic illnesses like diabetes, cancer, and cardiovascular diseases. Aging populations and lifestyle changes are increasing the demand for long-term treatments that are safer, more effective, and easier for patients to use. Advanced drug delivery systems help improve therapy outcomes while reducing side effects. The market is also benefiting from the growing adoption of modern therapies such as biologics, gene therapies, and RNA-based drugs. These treatments often require targeted and controlled delivery, which cannot be achieved through traditional methods like oral tablets or standard injections. This shift is fueling demand for innovative drug delivery platforms that offer precision, reduced dosing frequency, and better patient outcomes. Te...

 The Global Platelet Aggregation Devices Market is projected to grow from US$ 0.6 billion in 2024 to around US$ 1.1 billion by 2034, registering a CAGR of 6.6% during the forecast period. In 2024, North America dominated the market with over 40.1% share, reaching US$ 0.2 billion in revenue. This growth is mainly driven by the rising number of cardiovascular diseases. Health agencies worldwide report that more people are experiencing heart attacks and strokes. Since platelet function affects clotting, testing helps in early diagnosis and treatment planning. Hospitals and laboratories are increasingly using platelet aggregation devices to detect blood disorders. These include both excessive clotting and bleeding problems. Accurate testing helps doctors decide the best course of treatment. As awareness improves, more patients are being tested, supporting early intervention and better outcomes. Government health departments also highlight the value of platelet testing for long-te...

 The Global Self-Testing Market is projected to reach around US$ 25.8 billion by 2034, up from US$ 11.4 billion in 2024. This growth, at a CAGR of 8.5% , is fueled by rising consumer interest in managing health independently. People today want faster, private, and more convenient ways to monitor their well-being. The COVID-19 pandemic accelerated this shift, with millions turning to at-home testing to avoid clinics and reduce exposure. That trend has since extended to other health areas. One major driver is the global shift toward preventive healthcare. Governments and public health agencies are actively promoting early detection of diseases. Self-testing supports this goal by enabling people to check their health before symptoms appear. This leads to early treatment and helps ease the burden on hospitals and clinics. In particular, self-tests for diabetes, HIV, pregnancy, and infectious diseases are becoming more common across all age groups. Technology is also playing a vital ...